Genome-wide DNA methylation analysis in early-stage colorectal cancer

ABSTRACT: The current risk stratification system defined by clinicopathological features do not accurately identify the risk of disease recurrence in patients with stage I-II colorectal cancer (CRC). We aimed to investigate whether the CpG sites from newly established genome-wide methylation profiles could serve as biomarkers to improve prognosis prediction.

ORGANISM(S): Homo sapiens

PROVIDER: GSE119526 | GEO | 2023/04/19

REPOSITORIES: GEO